Comparison of 0.5% Levo-bupivacaine and 0.5% Ropivacaine in combined sciatic and femoral nerve block using ultrasound guidance in below knee orthopaedic surgery.

Comparative study of 0.5% Levo-bupivacaine versus 0.5% Ropivacaine in combined sciatic and femoral nerve block in below knee orthopedic surgery under ultrasound guidance. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070390

Enrollment

Registered

2024-07-10

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S829- Unspecified fracture of lower leg

Interventions

Intervention1: 0.5% Levo-bupivacaine: Under ultrasound guidance single dose of 12ml of 0.5% Levo-bupivacaine will be injected near sciatic nerve and single dose of 8ml of 0.5% Levo-bupivacaine will be

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade 1 and 2, no known neurological deficit, surgery - orthopaedic surgery below knee

Exclusion criteria

Exclusion criteria: ASA grade 3 and 4, patient with neurological disorders, history of allergy to study drug

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of 0.5% Levo-bupivacaine versus 0.5% Ropivacaine in combined sciatic and femoral nerve block under ultrasound guidance in patients undergoing below knee orthopaedic surgeryTimepoint: After induction End of surgery 12 hour postoperative	—

Secondary

Measure	Time frame
To study hemodynamic changes of 0.5% Levo-bupivacaine and 0.5% RopivacaineTimepoint: After induction End of surgery	—

Countries

India

Contacts

Public ContactDr. Saurabh Suman

Rajendra institute of medical science, Ranchi

Saurabh31.7.dmch@gmail.com7079893536

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026